The U.S. dried blood spot collection cards market size is anticipated to reach USD 149.9 million by 2030, growing at a CAGR of 3.9% during the forecast period. The rising application in newborn screening and expanding utilization of DBS cards in forensic toxicology are significant factors contributing to the market growth. According to the U.S. Department of Health & Human Services (HSS) and Health Resources & Services Administration (HRSA), each state of the U.S. possesses its legal list of requirements for screening newborns.
The growing adoption of dried blood spot collection cards in forensic toxicology and their increasing use in newborn screening is expanding the scope of these valuable diagnostic tools. These cards offer several advantages, such as ease of sample collection, storage stability, and cost-effectiveness. In forensic toxicology, DBS cards enable efficient detection of various substances, including drugs, alcohol, and toxins, in individuals. This information is crucial for determining the cause of death and identifying potential criminals.
In newborn screening, DBS cards facilitate early detection of genetic disorders and metabolic diseases, allowing for timely interventions and improved health outcomes for infants. As research progresses and analytical techniques continue to advance, the utilization of DBS cards in these fields is expected to expand further, benefiting forensic investigations and newborn healthcare, and contributing to the market.
The growing adoption of dried blood spot collection cards in forensic toxicology and their increasing use in newborn screening is expanding the scope of these valuable diagnostic tools. These cards offer several advantages, such as ease of sample collection, storage stability, and cost-effectiveness. In forensic toxicology, DBS cards enable efficient detection of various substances, including drugs, alcohol, and toxins, in individuals. This information is crucial for determining the cause of death and identifying potential criminals.
In newborn screening, DBS cards facilitate early detection of genetic disorders and metabolic diseases, allowing for timely interventions and improved health outcomes for infants. As research progresses and analytical techniques continue to advance, the utilization of DBS cards in these fields is expected to expand further, benefiting forensic investigations and newborn healthcare, and contributing to the market.
U.S. Dried Blood Spot Collection Cards Market Report Highlights
- Based on application, the newborn screening segment held the largest revenue share of 23.19% in 2023 and is expected to grow at a significant CAGR of 3.3% during the forecast period. The growth is attributed to the larger number of newborn screenings in the U.S.
- Based in card type, the Whatman 903 segment dominated the market with the largest revenue share of 32.33% in 2023 and is expected to grow at the fastest CAGR throughout the forecast period
- Based on end-use, the hospitals & clinics segment accounted for the largest revenue share in 2023. The segment is expected to exhibit a lucrative CAGR over the forecast period
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Dried Blood Spot Collection Cards Market Variables, Trends & Scope
Chapter 4. U.S. Dried Blood Spot Collection Cards Market: Application Estimates & Trend Analysis
Chapter 5. U.S. Dried Blood Spot Collection Cards Market: Card Type Estimates & Trend Analysis
Chapter 6. U.S. Dried Blood Spot Collection Cards Market: End-use Estimates & Trend Analysis
Chapter 7. U.S. Dried Blood Spot Collection Cards Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Whatman plc (Cytiva)
- GE Healthcare
- MilliporeSigma
- QIAGEN LLC
- PerkinElmer
- Roche
- Shimadzu Corporation
- Ahlstrom-Munksjö
- Eastern Business Forms, Inc.
- CENTOGENE N.V.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 70 |
| Published | May 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 115.3 Million |
| Forecasted Market Value ( USD | $ 149.9 Million |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 10 |
